Search Results

You are looking at 1 - 3 of 3 items for :

  • Endocrine Society of Australia special collection x
  • Refine by access: Content accessible to me x
Clear All
Jun Yang Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia
Department of Medicine, Monash University, Clayton, Victoria, Australia

Search for other papers by Jun Yang in
Google Scholar
PubMed
Close
,
Morag J Young Cardiovascular Endocrinology Laboratory, Discovery & Preclinical Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Search for other papers by Morag J Young in
Google Scholar
PubMed
Close
,
Timothy J Cole Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Timothy J Cole in
Google Scholar
PubMed
Close
, and
Peter J Fuller Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia

Search for other papers by Peter J Fuller in
Google Scholar
PubMed
Close

et al. 2005 ). The MR is unique in having two physiological agonist ligands, aldosterone and cortisol (corticosterone in rodents). However, they are not equivalent in that each induces subtly different conformations in the LBD with functional

Free access
Ken KY Ho Garvan Institute of Medical Research, St. Vincent’s Hospital and the UNSW Sydney, Sydney, New South Wales, Australia

Search for other papers by Ken KY Ho in
Google Scholar
PubMed
Close
,
Anthony J O’Sullivan St. George Hospital and the Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia

Search for other papers by Anthony J O’Sullivan in
Google Scholar
PubMed
Close
, and
Morton G Burt Southern Adelaide Diabetes and Endocrine, Flinders Medical Centre and College of Medicine and Public Health, and Flinders University, Adelaide, South Australia, Australia

Search for other papers by Morton G Burt in
Google Scholar
PubMed
Close

Interactions Consequence Thyroid GH enhances T4 conversion to T3 T4 falls during GH therapy Adrenal GH stimulates the conversion of active cortisol to inactive cortisone Risk of hypoadrenalism Gonadal Oestrogens impair GH

Free access
Sunita M C De Sousa Endocrine & Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia
South Australian Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia
Adelaide Medical School, University of Adelaide, Adelaide, Australia

Search for other papers by Sunita M C De Sousa in
Google Scholar
PubMed
Close
,
Nèle F Lenders Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Nèle F Lenders in
Google Scholar
PubMed
Close
,
Lydia S Lamb Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Lydia S Lamb in
Google Scholar
PubMed
Close
,
Warrick J Inder Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia
Academy for Medical Education, Faculty of Medicine, the University of Queensland, Brisbane, Australia

Search for other papers by Warrick J Inder in
Google Scholar
PubMed
Close
, and
Ann McCormack Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Ann McCormack in
Google Scholar
PubMed
Close

to APTs and PC ( Onguru et al. 2004 ). EGFR is overexpressed in invasive PAs ( Leriche et al. 1996 ) and correlates with tumour recurrence and cortisol/ACTH levels in Cushing’s disease ( Liu et al. 2019 ). The PI3K/Akt/mTOR and Raf

Free access